magpro transcranial magnetic stimulator (MagVenture inc)
90
Structured Review
MagVenture inc
magpro transcranial magnetic stimulator
Magpro Transcranial Magnetic Stimulator, supplied by MagVenture inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcranial+magnetic+stimulator/magpro+x100+stimulator/nct05236010-38-2-1
Average 90 stars, based on 1 article reviews
Magpro Transcranial Magnetic Stimulator, supplied by MagVenture inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcranial+magnetic+stimulator/magpro+x100+stimulator/nct05236010-38-2-1
Average 90 stars, based on 1 article reviews
magpro transcranial magnetic stimulator - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: 3D-mapping of TMS effects with automatic robotic placement improved reliability and the risk of spurious correlation. Article Snippet: The transcranial magnetic stimulator was a Article Title: Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson's disease: association with peripheral inflammatory regulatory T-cells and SYT6. Article Snippet: A total of 189 male mice were randomly divided into 9 groups as follows: (1) the saline normal control group (NC group, n = 21 mice) was only administered saline by intraperitoneal (i. p.) injection for 5 days; (2) the NC + sham rTMS group (NC + sham group, n = 21 mice), which were treated with i. p. injections of saline (30 mg/kg) for 5 days followed by sham rTMS treatment; (3) the NC + rTMS (10 Hz) group (n = 21 mice), which were administered i. p. doses of saline (30 mg/ kg) for 5 days before receiving rTMS (10 Hz) therapy; (4) the MPTP group (n = 21 mice), which received i. p. injections of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) (Sigma–Aldrich, USA) (30 mg/kg) for 5 days; (5) the MPTP + sham rTMS group (n = 21 mice), which were treated with i. p. injections of MPTP (30 mg/kg) for 5 days followed by sham rTMS treatment; (6) MPTP + rTMS (10 Hz) group (n = 21 mice), which were administered i. p. doses of MPTP (30 mg/kg) for 5 days before receiving rTMS (10 Hz) therapy; (7) the MPTP + block group (n = 21 mice), which received 3 days of continuous i. p. injections of anti-CD25 monoclonal antibodies (1 mg/kg) followed by 5 days of i. p. injections of MPTP (30 mg/kg); (8) the MPTP + block + sham (10 Hz) group (n = 21 mice), which was administered i. p. injections of anti-CD25 monoclonal antibodies (1 mg/kg, Thermo, USA) for 3 days before receiving i. p. injections of MPTP (30 mg/kg) for 5 days before receiving shamtherapy; and (9) the MPTP + block + rTMS (10 Hz) group (n = 21 mice), which was administered i. p. injections of anti-CD25 monoclonal antibodies (1 mg/kg, Thermo, USA) for 3 days before receiving i. p. injections of MPTP (30 mg/kg) for 5 days before receiving Article Title: Neurophysiological Differences between Flail Arm Syndrome and Amyotrophic Lateral Sclerosis Article Snippet: The motor evoked potentials (MEPs) were performed using a figure “8”-shaped magnetic coil with diameter of 96mm, connecting with Muscles:Article Title: Repetitive peripheral magnetic stimulation alone or in combination with repetitive transcranial magnetic stimulation in poststroke rehabilitation: a systematic review and meta-analysis Article Snippet: .. Intervention (I): Interventions that used rPMS applied to muscles and/or peripheral nerves of upper limbs, or cervical spinal nerves, or in combination with rTMS applied to the primary motor cortex (M1) cortical representations of the proximal or distal upper extremity; rPMS was delivered using a |
